Suppr超能文献

用 Lawsonia intracellularis 亚单位水包油乳剂疫苗进行免疫接种减轻了一些疾病参数,但未能影响脱落。

Vaccination with a Lawsonia intracellularis subunit water in oil emulsion vaccine mitigated some disease parameters but failed to affect shedding.

机构信息

Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E3, Canada; Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5B4, Canada.

Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E3, Canada; Department of Large Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5B4, Canada.

出版信息

Vaccine. 2024 Oct 24;42(24):126254. doi: 10.1016/j.vaccine.2024.126254. Epub 2024 Aug 29.

Abstract

Lawsonia intracellularis is the causative agent of ileitis in swine that manifests as slower weight gain, mild or hemorrhagic diarrhea and/or death in severe cases. As an economically important swine pathogen, development of effective vaccines is important to the swine industry. In developing a subunit vaccine with three recombinant antigens - FliC, GroEL and YopN - we wanted to identify a formulation that would produce robust immune responses that reduce disease parameters associated with Lawsonia intracellularis infection. We formulated these three antigens with four adjuvants: Montanide ISA 660 VG, Montanide Gel 02 PR, Montanide IMS 1313 VG NST, and Montanide ISA 61 VG in an immunogenicity study. Groups vaccinated with formulations including Montanide ISA 660 VG or Montanide ISA 61 VG had significantly more robust immune responses than groups vaccinated with formulations including Montanide Gel 02 PR or Montanide IMS 1313 VG NST. In the challenge study, animals vaccinated with these antigens and Montanide ISA 61 VG had reduced lesion scores, reduced lesion lengths, and increased average daily gain, but no reduction in shedding relative to the control animals. This work shows that this vaccine formulation should be considered for future study in a field and performance trial.

摘要

细胞内罗松菌是引起猪回肠炎的病原体,其症状表现为增重缓慢、轻度或出血性腹泻,严重时可能导致死亡。作为一种具有重要经济意义的猪病原体,开发有效的疫苗对于养猪业至关重要。在研发含有三种重组抗原(FliC、GroEL 和 YopN)的亚单位疫苗时,我们希望确定一种能够产生强大免疫反应、降低与细胞内罗松菌感染相关疾病参数的配方。我们将这三种抗原与四种佐剂(Montanide ISA 660 VG、Montanide Gel 02 PR、Montanide IMS 1313 VG NST 和 Montanide ISA 61 VG)进行了配方研究。在免疫原性研究中,接种含有 Montanide ISA 660 VG 或 Montanide ISA 61 VG 的配方的组产生了更强大的免疫反应,而接种含有 Montanide Gel 02 PR 或 Montanide IMS 1313 VG NST 的配方的组则免疫反应较弱。在攻毒研究中,接种这些抗原和 Montanide ISA 61 VG 的动物的病变评分、病变长度降低,平均日增重增加,但与对照组动物相比,粪便脱落量没有减少。这项工作表明,这种疫苗配方应该在未来的田间和性能试验中进行进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验